Clipping of news on Brazilian Culture, Law and Citizenship
 


Health

Anvisa publishes study on sale of appetite suppressants

06/29/2012

This article was translated by an automatic translation system, and was therefore not reviewed by people.

 

 



A study carried out by ANVISA for the sale of appetite suppressants suggests, among other things, distortions in relation to the continued use of these products and the drug combination with anxiolytics and antidepressants, vetoed by the Agency and the Federal Council of Medicine. The survey done by ANVISA in Brazilian state capitals and the Federal District (DF) considered the behavior of the consumption of amphetamines mazindol, amfepramone, fenproporex and sibutramine, based on data from the National Management System Controlled Products (SNGPC) and information from the Ministry Health

The SNGPC allows pharmacies to inform the Agency on the sale of medicines subject to special control. These data, before deploying the system, included only in record books.

The findings are the latest edition of the Bulletin of Pharmacoepidemiology SNGPC, published this month. The period covered was from 2009 to 2011, the year that Anvisa canceled the registration of the first three products (mazindol, amfepramone, fenproporex) and imposed a greater control over the marketing of sibutramine.

Contrary to what was expected, the prescription of appetite suppressants have an inverse relationship to the number of individuals with clinical obesity. The study found that for each 1% increase of the obese population, the consumption of inhibitors falls on average 8.3%.

The study has identified Anvisa also that 79% of consumers of appetite suppressants are repeated use of these products, ie products use as inhibitors of continuous use.

Despite the resolutions that determine the Federal Council of Medicine (CFM) and ANVISA, the research showed that the prescription of appetite suppressants had been combined with the antidepressant fluoxetine or anxiolytic chlordiazepoxide. This combination, however, is prohibited by Resolution No. 1477 CFM, published in 1997, and Board Resolution (RDC) Agency No. 58, published in 2007.

A positive finding of the survey is that consumption decreased appetite suppressants in the population of adults who have a diet rich in fruits and vegetables. It was observed in this study, an increase of 1% of the population adopts a healthy diet implies an average reduction of 4.3% on the sale of inhibitors.

Among the conclusions, the study of Anvisa recommends the improvement of health policies that enhance the rational use of medicines in the country, as the strengthening of continuing education in good prescribing practices.

As data were obtained

The study used data from the National Management of Controlled Products ANVISA (SNGPC), the National Health Agency (ANS) and the Ministry of Health From the data was applied econometric analysis used to identify the correlation between different
variables by means of a mathematical model.




Source: ANVISA

Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.